Pharmacy News

Semaglutide yields positive results for patients with obesity-related heart failure and T2D

Results of a new study published in NEJM found that semaglutide led to greater reductions in weight loss and heart failure–related symptoms in patients who had obesity-related heart failure with preserved ejection fraction and T2D compared with placebo.

Does biosimilar competition lower costs for patients?

Biosimilars have typically been viewed as cost-saving medications, but according to results of a study published in JAMA Health Forum, biosimilar competition did not consistently lower out-of-pocket costs for outpatients who were commercially insured. In fact, in some cases, costs even increased.

D-Mannose appears ineffective for UTI prevention

Authors of a new study said that “d-Mannose should not be recommended to prevent future episodes of medically attended UTI in women with recurrent UTI in primary care.”

Hormonal contraception will be available without a prescription in New York pharmacies

The New York State Department of Health issued an order in late March to formally implement a new law establishing access to hormonal contraception from pharmacists without a physician’s order.

Study links heart failure risk to e-cigarette use

Data from an NIH-led study found that people who used e-cigarettes were 19% more likely to develop heart failure compared with people who never vaped.